AlphaStocks
6.5
Consider Buy

Pediatrix Medical Group, Inc. (MD)

Health Care / Health Care Services

S&P SmallCap 600

$26.72

Middle of the pack. No strong signal either way.

Consider Buy

Score based on 4 of 5 models — moderate confidence

#153out of 1121 in Health Care

Is Pediatrix Medical Group, Inc. a Good Investment in 2026?

Pediatrix Medical Group, Inc. (MD) scores 6.5 out of 10 on AlphaStocks' composite model, earning a Consider Buy rating. The Greenblatt Magic Formula model rates Pediatrix Medical Group, Inc. as Strong (Top 25% (rank 16%)). However, the Graham model rates it Caution — 27% above fair value. Pediatrix Medical Group, Inc. currently trades below its estimated fair value of $35, suggesting potential upside. Pediatrix Medical Group, Inc. ranks #153 out of 1121 stocks in the Health Care sector.

This summary is algorithmically generated and is not financial advice.

Key Metrics

P/E13.8ROE18.8Market Cap2B

Estimated Fair Value

$35.0724% below

Fair value above market price. P/E of 14x is moderate for this quality level.

Model-based estimate, not a price target.

5-Model Analysis

Each model evaluates this stock from a different angle. Combined, they form the composite score above.

Piotroski

Attractive

6/9

Buffett

Attractive

Business quality & competitive moat

Graham

Caution

27% above fair value

Lynch

Neutral

Growth rate vs price (PEG)

Greenblatt

Strong

Top 25% (rank 16%)

Frequently Asked Questions

Is Pediatrix Medical Group, Inc. (MD) a good investment?
Based on AlphaStocks' composite analysis, Pediatrix Medical Group, Inc. (MD) scores 6.5 out of 10, earning a Consider Buy rating. This is a middle-of-the-pack score with no strong signal either way. Fair value above market price. P/E of 14x is moderate for this quality level.
What is Pediatrix Medical Group, Inc.'s Piotroski F-Score?
Pediatrix Medical Group, Inc.'s Piotroski F-Score status is Attractive. The raw score is 6/9. The Piotroski F-Score evaluates financial health using 9 fundamental signals including profitability, leverage, and operating efficiency.
Is MD overvalued or undervalued?
Based on AlphaStocks' model-based fair value estimate of $35, MD appears undervalued. The stock currently trades 24% below its estimated fair value. Fair value above market price. P/E of 14x is moderate for this quality level.
How does MD compare to other Health Care stocks?
Pediatrix Medical Group, Inc. ranks #153 out of 1121 stocks in the Health Care sector, placing it in the top 14% of its sector by composite score. This is a strong position relative to sector peers.
What do investment models say about MD?
AlphaStocks evaluates MD using five proven investment models. Piotroski: Attractive; Buffett: Attractive; Graham: Caution; Lynch: Neutral; Greenblatt Magic Formula: Strong. These models are combined into a single composite score of 6.5/10.

Similar Stocks

PARRBFAMAZN

Compare MD with

MD vs PARRMD vs BFAMMD vs AZN

Scores are algorithm-generated research tools, not investment recommendations. Past performance does not guarantee future results. Always do your own due diligence. Full disclaimer